Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01218854 · ClinicalTrials.gov registry record · Phase 1

A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy

A Phase 1 study, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
Phase 1
Development phase
17
Enrollment target

NCT01218854 is a Phase 1 study that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01218854, a Phase 1 study, has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
Phase 1
Development phase
17 participants
Enrollment target

Study Summary

Background: \- Currently, standard procedures for biopsies that are guided by computed tomography (CT) imaging involve CT scans and a computer program to plan and illustrate where the physician will place the needle to obtain the required cells or tissue. Inserting the biopsy needle at the planned angle is not an easy task, because the appropriate angle of insertion must be estimated based on prior experience. Researchers are studying experimental techniques that might provide better guidance about the right angle to insert the biopsy needle and thereby improve the collection of the appropriate biopsy cells or tissue. Objectives: \- To evaluate the effectiveness of two biopsy needle guidance methods in CT-guided tissue biopsy. Eligibility: \- Individuals at least 18 years of age who are scheduled to have CT-guided tissue biopsy. Design: * Participants will have a tissue biopsy guided by CT scans and either a laser system or a plastic block to illustrate the appropriate angle of insertion. The skin will be numbed with anesthetic to minimize discomfort during the procedure. * Before inserting the biopsy needle, the study physician will hold the needle in place so that a Food and Drug Administration-approved medical GPS (electromagnetic tracking) system can measure the needle angle as it enters the tissue. * After the needle angle data has been collected, researchers will proceed with the actual biopsy procedure as it would normally occur, using standard methods. * No additional treatment will be provided as part of this protocol.

Interventions

  • DEVICE Needle angle measurement

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2012-03-20
Est. Completion 2016-11-16
Phase Phase 1

What the Registry Record Tells You About NCT01218854

The ClinicalTrials.gov registry entry for NCT01218854 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Needle angle measurement is the first listed.

NCT01218854 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01218854 about?

NCT01218854 is a clinical study titled "A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy". Background: \- Currently, standard procedures for biopsies that are guided by computed tomography (CT) imaging involve CT scans and a computer program to plan and illustrate where the physician will place the needle to obtain the required cells or tissue. Inserting the biopsy needle at the planned ...

What is the current status of trial NCT01218854?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2012-03-20. Estimated completion is 2016-11-16.

What interventions are being tested in trial NCT01218854?

The interventions under investigation include: Needle angle measurement (DEVICE).

Who is sponsoring clinical trial NCT01218854?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.